Beroni Group, an Australia-based biopharmaceutical enterprise, has signed a Memorandum of Understanding with tella, Inc. to collaborate in the field of immunotherapy for cancer treatment. tella is a Japanese company working to develop cancer vaccines. tella’s dendritic cell vaccine therapy aims to increase the dendritic cell population and strengthen the attacking system against cancers. In 2019, tella’s dendritic cell vaccine therapy was provided to approximately 12,200 patients in 28 medica...